Photodynamic therapy (PDT) using a hematoporphyrin derivative (HpD), and its more purified form dihematoporphyrin ether (DHE), in combination with dye laser systems is undergoing a great deal of study for treatment of a variety of cancers. Results to date are promising in a number of tumor types and organs. The mode of delivery of the activating light, the dosimetry of light delivered, and the therapeutic reaction obtained are extremely important in obtaining significant and selective tumor response.

© 1984 Optical Society of America

PDF Article


You do not have subscription access to this journal. Citation lists with outbound citation links are available to subscribers only. You may subscribe either as an OSA member, or as an authorized user of your institution.

Contact your librarian or system administrator
Login to access OSA Member Subscription